These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5911913)

  • 1. [Papaverine in high doses in the treatment of cerebral circulatory insufficiency in senescence and senility. (Clinico-statistical study of 474 cases)].
    Ferliga G
    G Gerontol; 1966 Apr; 14(4):345-63. PubMed ID: 5911913
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of papaverine on systemic and cerebral hemodynamics in atherosclerosis complicated by chronic cerebral circulatory insufficiency].
    Komorovskaia IaM; Nechaĭ EE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1308-12. PubMed ID: 6506974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative trials of various therapeutics relating to cerebral vessels].
    Brion S; Guérin R
    Nouv Presse Med; 1975 Aug 30-Sep 6; 4(28):2035-6. PubMed ID: 1101201
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment and prevention of cerebral arterial disorders in aged and of their consequences. Rheoencephalographic examinations].
    Albot G; Goutmer B; Treps J
    Therapeutique; 1971; 47(6):579-84. PubMed ID: 5571174
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of cerebral circulatory insufficiency. Double-blind study of the efficacy of a quinine-papaverine combination].
    Klemm J
    Fortschr Med; 1984 Oct; 102(39):1000-2. PubMed ID: 6389288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience with the combination of vincamine and papaverine in chronic brain syndrome].
    Cacciatori D
    Clin Ter; 1979 Jun; 89(5):473-82. PubMed ID: 535324
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of the effectiveness of papaverine in the long-term therapy of cerebral ischemia].
    Dam M; Battistin L
    Clin Ter; 1981 Dec; 99(5):483-8. PubMed ID: 7333069
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of cerebral vascular diseases due to softening].
    Tomaselli R; Elia C
    Omnia Med Ther; 1968; 46(3):657-70. PubMed ID: 4989937
    [No Abstract]   [Full Text] [Related]  

  • 9. [Trial of eutergine in chronic cerebral arteriopathies].
    Pauchant M; Bernard JM
    Lille Med; 1972 May; 17():Suppl 4:819-23. PubMed ID: 4626797
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cerebrovascular disorders. Conservative therapy using Kollateral forte].
    Feine-Haake G
    ZFA (Stuttgart); 1980 Mar; 56(8):575-8. PubMed ID: 7415502
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of papaverine on cerebrospinal fluid and blood acid-base balance in patients with vascular diseases of the brain].
    Gabrielian ES; Zograbian SG; Amroian EA; Dadivanian IuP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(8):1168-72. PubMed ID: 973520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of theophyllinyl 7- -n propane sulfonate of papaverine in rehabilitation and functional readaptation].
    Blanc A; Perset P
    Therapeutique; 1971 Apr; 47(4):391-3. PubMed ID: 5564052
    [No Abstract]   [Full Text] [Related]  

  • 13. [Method of approach and psychometric evaluation of the aged in circulatory therapeutics of the brain].
    Soulairac A; Losson JP; Losson M
    Therapeutique; 1969 Dec; 45(10):1025-9. PubMed ID: 5386099
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study of the clinical effect of vincamine versus papaverine given parenterally in the acute phase of stroke.
    Thiery E; Otte G; Vander Eecken H
    Arzneimittelforschung; 1979; 29(3):671-4. PubMed ID: 582751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of a new vasodilating agent (Dilydrin) in cerebral vascular disorders and strokes].
    Probst G; Keiser G
    Praxis; 1969 Dec; 58(50):1653-8. PubMed ID: 4905566
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term medical treatment of acute cerebrovascular disease sequelae (comparison papaverine-piribedil].
    Piccinelli A; Neri G; Agnoli A
    Minerva Med; 1974 Nov; 65(80):4199-213. PubMed ID: 4610451
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of treatment with SEN DCS-1. Preliminary note on 24 patients].
    Pastor Franco A
    Rev Clin Esp; 1970 Aug; 118(4):359-64. PubMed ID: 4991986
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study in internal medicine of a drug combination with vascular effects. Apropos of 82 cases using eutergine].
    Albeaux-Fernet M; Romani JD
    Sem Hop; 1968 May; 44(22):1526-8. PubMed ID: 4302769
    [No Abstract]   [Full Text] [Related]  

  • 19. [Attempt at psychometric evaluation of aging: study of a vascular drug].
    Losson M; Losson JP
    Therapeutique; 1969 Mar; 45(3):313-7. PubMed ID: 4989246
    [No Abstract]   [Full Text] [Related]  

  • 20. Papaverine for cerebral and other vascular disorders.
    Med Lett Drugs Ther; 1970 Mar; 12(6):26-7. PubMed ID: 5510015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.